当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析

康泰医学

(300869)

  

流通市值:39.22亿  总市值:62.64亿
流通股本:2.52亿   总股本:4.02亿

康泰医学(300869)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.95亿元,每股收益0.49元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益207471.81万元,未分配利润113712.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产346623.18万元,负债139151.37万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入617,227,119.11494,479,138.73368,699,882.77712,114,538.93
营业总成本429,154,337.97311,657,488.01197,193,260.98551,697,858.22
营业利润220,339,813.86210,650,417.56188,205,059.3219,275,712.94
利润总额220,165,922.14210,279,094.05187,935,164.53219,394,332.74
净利润195,117,554.43182,886,433.38170,052,052.02196,202,558.53
其他综合收益1,332,195.881,625,989.34-559,565.392,992,641.92
综合收益总额196,449,750.31184,512,422.72169,492,486.63199,195,200.45
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,636,067,417.342,847,788,363.992,943,249,312.272,558,415,892.24
非流动资产合计830,164,396.4817,413,886.41743,334,746.371,174,389,940.21
资产总计3,466,231,813.743,665,202,250.43,686,584,058.643,732,805,832.45
流动负债合计692,252,107.01906,466,294.52896,510,947.791,112,558,191.38
非流动负债合计699,261,564.49695,956,336.17692,177,654.59691,913,811.81
负债合计1,391,513,671.51,602,422,630.691,588,688,602.381,804,472,003.19
归属于母公司股东权益合计2,074,718,142.242,062,779,619.712,097,895,456.261,928,333,829.26
股东权益合计2,074,718,142.242,062,779,619.712,097,895,456.261,928,333,829.26
负债和股东权益合计3,466,231,813.743,665,202,250.43,686,584,058.643,732,805,832.45
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计838,260,774.94681,983,587.89410,840,410.94796,938,560.84
经营活动现金流出小计660,538,460.96525,078,066.05309,324,055.31693,281,708.51
经营活动产生的现金流量净额177,722,313.98156,905,521.84101,516,355.63103,656,852.33
投资活动现金流入小计121,754,759.57120,720,426.2326,683,525.0522,309,844.77
投资活动现金流出小计838,773,729.34192,511,173.9186,077,337.52136,134,028.07
投资活动产生的现金流量净额-717,018,969.77-71,790,747.67-159,393,812.47-113,824,183.3
筹资活动现金流入小计752,371,600.44752,655,220.84322,376,199.41,744,977,357.32
筹资活动现金流出小计1,244,315,368.571,038,571,677.5533,152,263.57963,639,451.96
筹资活动产生的现金流量净额-491,943,768.13-285,916,456.66-210,776,064.17781,337,905.36
汇率变动对现金及现金等价物的影响6,881,813.017,322,803.218,989,326.2217,580,131.13
现金及现金等价物净增加额-1,024,358,610.91-193,478,879.28-259,664,194.79788,750,705.52
期末现金及现金等价物余额362,964,487.151,193,844,218.781,127,658,903.271,387,323,098.06
TOP↑